96 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Teva facing EU fine for disparaging Copaxone rival: report https://seekingalpha.com/news/4148424-teva-facing-eu-fine-for-disparaging-copaxone-rival-report?source=feed_tag_israel Sep 10, 2024 - Teva (TEVA) is facing a fine by EU regulators for allegedly disparaging a product that competes with its multiple sclerosis drug Copaxone, according to Reuters. Read more here.
Cheap Teva Stock Should Reward Patient Investors https://seekingalpha.com/article/4719969-cheap-teva-stock-should-reward-patient-investors?source=feed_tag_israel Sep 09, 2024 - Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. Learn more about TEVA stock here.
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4719125-teva-pharmaceutical-industries-limited-teva-morgan-stanley-22nd-annual-global-healthcare?source=feed_tag_israel Sep 04, 2024 - Teva Pharmaceutical Industries Limited (NYSE:TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 4, 2024 11:30 AM ETCompany...
Teva Pharmaceutical hits a new 52-week high https://seekingalpha.com/news/4139984-teva-pharmaceutical-stock-hits-new-52-week-high?source=feed_tag_israel Aug 14, 2024 - Teva Pharmaceutical (TEVA) stock hits a new 52-week high on Friday as Wall Street analysts and Seeking Alpha analysts tout its bullish prospects. Read more here.
Teva Pharmaceutical Industries Limited (TEVA) Q2 2024 Earnings Call Transcript https://seekingalpha.com/article/4708652-teva-pharmaceutical-industries-limited-teva-q2-2024-earnings-call-transcript?source=feed_tag_israel Jul 31, 2024 - Teva Pharmaceutical Industries Limited (NYSE:NYSE:TEVA) Q2 2024 Earnings Conference Call July 31, 2024 8:00 AM ETCompany ParticipantsRichard Francis -...
Teva Pharmaceutical Industries Limited 2024 Q2 - Results - Earnings Call Presentation https://seekingalpha.com/article/4708478-teva-pharmaceutical-industries-limited-2024-q2-results-earnings-call-presentation?source=feed_tag_israel Jul 31, 2024 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2024 Q2 earnings call.
Teva gains after lifting outlook on YTD performance https://seekingalpha.com/news/4130982-teva-stock-gains-revised-outlook?source=feed_tag_israel Jul 31, 2024 - Teva Pharmaceutical (TEVA) stock gained after the reported strong Q2 2024 financials, raising its full-year outlook. Read more here.
Teva Pharmaceutical beats Q2 estimates, raises outlook https://seekingalpha.com/news/4130883-teva-pharmaceutical-beats-q2-estimates-raises-outlook?source=feed_tag_israel Jul 31, 2024 - Teva Pharmaceutical announces strong Q2 results with Non-GAAP EPS beating estimates by $0.06 and revenue exceeding by $150M.
Teva Pharmaceutical Q2 2024 Earnings Preview https://seekingalpha.com/news/4130294-teva-pharmaceutical-q2-2024-earnings-preview?source=feed_tag_israel Jul 30, 2024 - Teva Pharmaceutical (TEVA) is set to announce Q2 earnings on July 31st.
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs https://seekingalpha.com/article/4707032-teva-q2-earnings-preview-key-developments-biosimilars-pipeline-drugs?source=feed_tag_israel Jul 26, 2024 - Teva Pharmaceutical stock is up 69% since December. The company is set for Q2 earnings on July 31. See why I maintain my Hold rating on TEVA stock.

Pages: 12345678910

<<<Page 4>